Supriya Lifescience Ltd

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Monday February 09 2026 inter-alia considered and approved the following: Unaudited Financial Results Change in Directorate - Appointment/ Re-appointment of Independent Directors Reconstitution of Committees of the Board.The details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read along with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 are enclosed herewith.The Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 05.00 p.m.Kindly take the above information on your records.